Cargando…

Ferroptosis in hematological malignant tumors

Ferroptosis is a kind of iron-dependent programmed cell death discovered in recent years. Its main feature is the accumulation of lipid reactive oxygen species in cells, eventually leading to oxidative stress and cell death. It plays a pivotal role in normal physical conditions and the occurrence an...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yong, Du, Zefan, Huang, Junbin, Li, Tianwen, Zhang, Jing, Li, Yixian, Yi, Wenfang, Chen, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149970/
https://www.ncbi.nlm.nih.gov/pubmed/37139157
http://dx.doi.org/10.3389/fonc.2023.1127526
_version_ 1785035262620860416
author Liu, Yong
Du, Zefan
Huang, Junbin
Li, Tianwen
Zhang, Jing
Li, Yixian
Yi, Wenfang
Chen, Chun
author_facet Liu, Yong
Du, Zefan
Huang, Junbin
Li, Tianwen
Zhang, Jing
Li, Yixian
Yi, Wenfang
Chen, Chun
author_sort Liu, Yong
collection PubMed
description Ferroptosis is a kind of iron-dependent programmed cell death discovered in recent years. Its main feature is the accumulation of lipid reactive oxygen species in cells, eventually leading to oxidative stress and cell death. It plays a pivotal role in normal physical conditions and the occurrence and development of various diseases. Studies have shown that tumor cells of the blood system, such as leukemia cells and lymphoma cells, are sensitive to the response to ferroptosis. Regulators that modulate the Ferroptosis pathway can accelerate or inhibit tumor disease progression. This article reviews the mechanism of ferroptosis and its research status in hematological malignancies. Understanding the mechanisms of ferroptosis could provide practical guidance for treating and preventing these dreaded diseases.
format Online
Article
Text
id pubmed-10149970
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101499702023-05-02 Ferroptosis in hematological malignant tumors Liu, Yong Du, Zefan Huang, Junbin Li, Tianwen Zhang, Jing Li, Yixian Yi, Wenfang Chen, Chun Front Oncol Oncology Ferroptosis is a kind of iron-dependent programmed cell death discovered in recent years. Its main feature is the accumulation of lipid reactive oxygen species in cells, eventually leading to oxidative stress and cell death. It plays a pivotal role in normal physical conditions and the occurrence and development of various diseases. Studies have shown that tumor cells of the blood system, such as leukemia cells and lymphoma cells, are sensitive to the response to ferroptosis. Regulators that modulate the Ferroptosis pathway can accelerate or inhibit tumor disease progression. This article reviews the mechanism of ferroptosis and its research status in hematological malignancies. Understanding the mechanisms of ferroptosis could provide practical guidance for treating and preventing these dreaded diseases. Frontiers Media S.A. 2023-04-17 /pmc/articles/PMC10149970/ /pubmed/37139157 http://dx.doi.org/10.3389/fonc.2023.1127526 Text en Copyright © 2023 Liu, Du, Huang, Li, Zhang, Li, Yi and Chen https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Liu, Yong
Du, Zefan
Huang, Junbin
Li, Tianwen
Zhang, Jing
Li, Yixian
Yi, Wenfang
Chen, Chun
Ferroptosis in hematological malignant tumors
title Ferroptosis in hematological malignant tumors
title_full Ferroptosis in hematological malignant tumors
title_fullStr Ferroptosis in hematological malignant tumors
title_full_unstemmed Ferroptosis in hematological malignant tumors
title_short Ferroptosis in hematological malignant tumors
title_sort ferroptosis in hematological malignant tumors
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149970/
https://www.ncbi.nlm.nih.gov/pubmed/37139157
http://dx.doi.org/10.3389/fonc.2023.1127526
work_keys_str_mv AT liuyong ferroptosisinhematologicalmalignanttumors
AT duzefan ferroptosisinhematologicalmalignanttumors
AT huangjunbin ferroptosisinhematologicalmalignanttumors
AT litianwen ferroptosisinhematologicalmalignanttumors
AT zhangjing ferroptosisinhematologicalmalignanttumors
AT liyixian ferroptosisinhematologicalmalignanttumors
AT yiwenfang ferroptosisinhematologicalmalignanttumors
AT chenchun ferroptosisinhematologicalmalignanttumors